< Back to Article

Impact of Obesity on the Bioavailability of Peginterferon-α2a and Ribavirin and Treatment Outcome for Chronic Hepatitis C Genotype 2 or 3

Figure 3

Impact of obesity on ribavirin concentrations.

Box plots displaying the 10^th, 25^th, 50^th, 75^th, and 90^th percentiles of the plasma concentrations of ribavirin (µg/mL) treatment day 29 and week 12 (A and B respectively). P-values obtained using Mann-Whitney U-test.

doi: https://doi.org/10.1371/journal.pone.0037521.g003